These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15153158)

  • 1. Geographically dependent distribution of gyrA gene mutations at codons 83 and 87 in Salmonella Hadar, and a novel codon 81 Gly to His mutation in Salmonella Enteritidis.
    Lindstedt BA; Aas L; Kapperud G
    APMIS; 2004 Mar; 112(3):165-71. PubMed ID: 15153158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal expansion may account for high levels of quinolone resistance in Salmonella enterica serovar enteritidis.
    Kilmartin D; Morris D; O'Hare C; Corbett-Feeney G; Cormican M
    Appl Environ Microbiol; 2005 May; 71(5):2587-91. PubMed ID: 15870349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of gyrA Mutations in Nalidixic Acid-Resistant Strains of Salmonella Enteritidis Isolated from Humans, Food, Chickens, and the Farm Environment in Brazil.
    Campioni F; Souza RA; Martins VV; Stehling EG; Bergamini AMM; Falcão JP
    Microb Drug Resist; 2017 Jun; 23(4):421-428. PubMed ID: 27559761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of nalidixic acid and ciprofloxacin with wild type and mutated quinolone-resistance-determining region of DNA gyrase A.
    Vashist J; Vishvanath ; Kapoor R; Kapil A; Yennamalli R; Subbarao N; Rajeswari MR
    Indian J Biochem Biophys; 2009 Apr; 46(2):147-53. PubMed ID: 19517991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of novel gyrA mutations in nalidixic acid-resistant isolates of Salmonella enterica from patients with diarrhoea.
    Hamidian M; Tajbakhsh M; Tohidpour A; Rahbar M; Zali MR; Walther-Rasmussen J
    Int J Antimicrob Agents; 2011 Apr; 37(4):360-4. PubMed ID: 21371866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone Resistance Determinants of Clinical Salmonella Enteritidis in Thailand.
    Utrarachkij F; Nakajima C; Changkwanyeun R; Siripanichgon K; Kongsoi S; Pornruangwong S; Changkaew K; Tsunoda R; Tamura Y; Suthienkul O; Suzuki Y
    Microb Drug Resist; 2017 Oct; 23(7):885-894. PubMed ID: 28437229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of mutations in the gyrA gene and class I integron from quinolone-resistant Salmonella enterica serovar Choleraesuis isolates in Taiwan.
    Huang TM; Chang YF; Chang CF
    Vet Microbiol; 2004 Jun; 100(3-4):247-54. PubMed ID: 15145503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
    Guo Y; Pei X; Liu X
    Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance.
    Choi SH; Woo JH; Lee JE; Park SJ; Choo EJ; Kwak YG; Kim MN; Choi MS; Lee NY; Lee BK; Kim NJ; Jeong JY; Ryu J; Kim YS
    J Antimicrob Chemother; 2005 Dec; 56(6):1111-4. PubMed ID: 16244086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the gyrA gene in Salmonella enterica clinical isolates with decreased ciprofloxacin susceptibility.
    Escribano I; Rodríguez JC; Royo G
    Int J Antimicrob Agents; 2004 Sep; 24(3):300-3. PubMed ID: 15325438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of quinolone resistance and mutations in the topoisomerase genes in Salmonella enterica serotype Enteritidis isolates from Serbia.
    Kozoderović G; Velhner M; Jelesić Z; Golić N; Lozo J; Kehrenberg C
    Int J Antimicrob Agents; 2012 Nov; 40(5):455-7. PubMed ID: 22999768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mutations in Salmonella enterica gyrA, gyrB, parC and parE genes by denaturing high performance liquid chromatography (DHPLC) using standard HPLC instrumentation.
    Randall LP; Coldham NG; Woodward MJ
    J Antimicrob Chemother; 2005 Oct; 56(4):619-23. PubMed ID: 16141278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
    Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
    J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of gyrA and parC mutations in quinolone-resistant Salmonella enterica using Pyrosequencing technology.
    Hopkins KL; Arnold C; Threlfall EJ
    J Microbiol Methods; 2007 Jan; 68(1):163-71. PubMed ID: 16934351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing.
    Beckmann L; Müller M; Luber P; Schrader C; Bartelt E; Klein G
    J Appl Microbiol; 2004; 96(5):1040-7. PubMed ID: 15078520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance in clinical isolates of Salmonella enterica serotype Enteritidis: relationships between mutations conferring quinolone resistance, integrons, plasmids and genetic types.
    Soto SM; González-Hevia MA; Mendoza MC
    J Antimicrob Chemother; 2003 May; 51(5):1287-91. PubMed ID: 12668577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and molecular characterization of quinolone resistant Salmonella spp. from poultry farms.
    San Martín B; Lapierre L; Toro C; Bravo V; Cornejo J; Hormazabal JC; Borie C
    Vet Microbiol; 2005 Oct; 110(3-4):239-44. PubMed ID: 16153786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
    J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003).
    Davies TA; Yee YC; Goldschmidt R; Bush K; Sahm DF; Evangelista A
    J Antimicrob Chemother; 2006 Mar; 57(3):437-42. PubMed ID: 16431861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of topoisomerase mutations in fluoroquinolone-resistant and -susceptible Campylobacter jejuni strains isolated in Senegal.
    Kinana AD; Cardinale E; Bahsoun I; Tall F; Sire JM; Garin B; Boye CS; Dromigny JA; Perrier-Gros-Claude JD
    Int J Antimicrob Agents; 2007 Apr; 29(4):397-401. PubMed ID: 17224260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.